Statins and thrombin

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 5, Issue 2, 2005, Pages 115-120

  Fenton II, J W ^a   Brezniak, D V ^a   Ofosu, F A ^b   Shen, G X ^c   Jacobson, J R ^d   Garcia, J G N ^d  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BLOOD CLOTTING FACTOR 10A; CERIVASTATIN; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FARNESYL DIPHOSPHATE; GERANYLGERANYL PYROPHOSPHATE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 8; ISOPRENOID; MEMBRANE PROTEIN; MEVALONIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTHROMBIN; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN; TRYPTASE;

CHOLESTEROL METABOLISM; CONCENTRATION RESPONSE; CONJUGATION; DOWN REGULATION; HUMAN; HUMAN CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PLEIOTROPY; PREDICTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; TIME;

DOWN-REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; THROMBIN;

EID: 18544364319     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006043586189     Document Type: Review

References (58)

1. Mahler, H.R.; Cordes, E.H. Biological Chemistry; Harper & Row: New York and London, 1966, pp. 624-652.
2. Goldstein, J.L.; Brown, M.S. Regulation of the mevalonate pathway. Nature 1990, 343, 425-430.
3. Maltese, W.A. Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J. 1990, 4, 3319-3328.
4. Fenton II, J.W.; Shen, G.X.; Minnear, F.L.; Brezniak, D.V.; Walenga, J.M.; Bognacki, J.J.; Ofosu, F.A. Statins induce hypothrombotic states? Clin. Appl. Thromb./Hemost. 2000, 6, 18-21.
5. Fenton II, J.W.; Shen, G.X.; Minnear, F.L.; Brezniak, D.V.; Jeske, W.P.; Walenga, J.M.; Bognacki, J.J.; Ofosu, F.A.; Hassouna., H.I. Statin drugs and dietary isoprenoids as antithrombotic agents. Hematol./Oncol. Clin. North Am. 2000, 14, 483-490.
6. Fenton II, J.W.; Jeske, W.P.; Catalfamo, J.L.; Brezniak, D.V.; Moon, D.G.; Shen, G.X. Statin drugs and dietary isoprenoids downregulate protein prenylation in signal transduction and are antithrombotic and prothrombolytic agents. Biochemistry (Moscow) 2002, 67, 99-106.
7. Elson, C.E. Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease. J. Nutr. 1995, 125, 16665-16725.
8. Davignon, J. The pleiotrophic effects of drugs affecting lipid metabolism. In Atherosclerosis; Jacotot, B., Mathe, D., Fruchart J.-C., Eds.; Elsevier: Amsterdam, 1998, pp. 63-77.
9. Takemoto, M.; Liao, J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arteriosceleros. Thrombos. Vas. Biol. 2001, 21, 1712-1719.
10. Palinski, W.; Napoli, C. Unraveling pleiotropic effects of statins on plaque rupture. Arteriosceleros. Thrombos. Vas. Biol. 2002, 22, 1745-1750.
11. Coughlin, S.R. Protease-activated receptors in vascular biology. Thromb. Haemost. 2001, 86, 298-307.
12. Coughlin, S.R.; Camerer, E. PARticipation in inflammation. J. Clin. Invest. 2003, 111, 25-27.
13. Patterson, C.; Stouffer, G.A.; Madamanchi, N.; Runge, M.S. New tricks for old dogs. Non-thrombotic effects of thrombin in vessel wall biology. Circ. Res. 2001, 88, 987-997.
14. Fenton II, J.W.; Ofosu, F.A.; Brezniak, D.V.; Hassouna, H.I. Understanding thrombin and hemostasis. Hematol/Oncol, Clin. North Am. 1993, 7, 1107-1119.
15. Fenton II, J.W. Thrombin functions and antithrombotic intervention. Thromb. Haemost. 1995, 74, 493-498.
16. Fenton II, J.W.; Ofosu, F.A.; Brezniak, D.V.; Hassouna, H.I. Thrombin and antithrombotics. Semin. Thromb. Hemost. 1998, 24, 87-91.
17. Rosenson, R.S.; Tangney, C.C. Antiantherothrombotic properties of statins. J. Am. Med. Assoc. 1998, 279, 1643-1650.
18. Fenton II, J.W.; Shen, G.X. Statins as cellular antithrombotics. In Lectures; Ulutin, O.N., Ed.; 15th International Congress on Thrombosis: Antalya, Turkey, 1998, pp. 112-114.
19. Fenton II, J.W.; Shen, G.X. Statins as cellular antithrombotics. Haemostasis 1999, 29, 166-169.
20. Farmer, J.A. Learning from the cerivastatin experience. Lancet 2001, 358, 1383-1385.
21. Downton, D.; Clark, I. Statins - the heart of the matter. Nature Rev. Drug Discovery 2003, 2, 343.
22. Clarke, S. Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Ann. Rev. Biochem. 1992, 61, 355-386.
23. Zhang, F.L.; Casey, P.J. Protein prenylation: molecular mechanisms and functional consequences. Ann. Rev. Biochem. 1996, 65, 241-269.
24. Colli, S.; Eligini, S.; Lalli, M.; Camera, M.; Paoletti, R.; Tremoli, E. Vastatins inhibit tissue factor in cultured human macrophages. Arteriosceleros. Thrombos. Vas. Biol. 1997, 17, 265-272.
25. Ando, H.; Takamura, T.; Ota, T.; Nagai, Y.; Kobayashi, K.-I. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J. Pharmacol. Expl. Therapeutics 2000, 294, 1043-1046.
26. Holstein, S.A.; Wohlford-Lenane, D.F.; Wiemer, D.F.; Hohl, R.J. Isoprenoid pyrophophate analogues regulate expression of Ras-related proteins. Biochemistry 2003, 42, 4384-4391.
27. Jacobson, J.; Dudek, S.; Birukov, K.; Ye, S.; Grigoryev, D.; Girgis, R.; Garcia, J. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am. J. Respir. Cell Mol. Biol. 2004, 30, 662-670.
28. Sandmann, G. Carotenoid biosynthesis and biotechnological application. Arch. Biochem. Biophys. 2001, 385, 4-12.
29. Santoro, M.G.; Rosi, A.; Amici, C. NF-κB and virus infection: who controls whom. EMBO J. 2003, 22, 2552-2560.
30. Brandes, R.P.; Beer, S.; Ha, T.; Busse, R. Withdrawal of cerivastatin induces monocyte chemoattractant protein I and tissue factor expression in cultured vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1794-1800.
31. Kolb, H. How the retina works. Much of the construction of an image takes place in the retina itself through the use of specialized neural circuits. Am. Scient. 2003, 91, 28-35.
32. Mirzadegan, T.; Benko, G.; Filipek, S.; Palczewski, K. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 2003, 42, 2759-2767.
33. i - linked Ras/mitogen-activated protein kinase pathway. J. Biol. Chem. 1999, 274, 13718-13727.
34. Missy, K.; Plantavid, M.; Pacaud, P.; Viala, C.; Chap, H.; Payrastre, B. Rho-kinase is involved in the sustained phosphorylation of myosin and the irreversible platelet aggregation induced by PAR 1 activating peptide. Thromb. Haemost. 2001, 85, 514-520.
35. van Nieuw Amerongen, G.P.; van Delft, S.; Vermeer, M.A.; Collard, J.G.; van Hinsberg, V.W.M. Activation of RhoA by thrombin in endothelial hyperpermeability. Role of Rho kinase and protein tyrosine kinase. Circ. Res. 2000, 87, 335-340.
36. Romano, M.; Marulli, C.; Ciabattoni, G.; Mezzetti, A.; Febo, F.; Di Lenno, S.; Roccaforte, S., Vigneri, S.; Nubile, G.; Milani, M.; Davi, G. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients. Circulation 1998, 98, 4198, abstract.
37. Kipl. J. Biol. Chem. 1999, 274, 21926-21931.
38. Shi, J.; Wang, H.; Zheng, W.; Ling, W.; Joseph, J.; Li, D.; Mehta, J.L.; Ponneppan, U.; Lin, P.; Fink, L.M.; Hauer-Jensen, M. Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul. Fibrinoly. 2003, 14, 575-585.
39. Ferro, D.; Basili, A.C.; Mantovani, B.; Cordova, C.; Violi, F. Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia. Lancet 1997, 350, 1222.
40. Essig, M.; Nguyen, G.; Prie, D.; Escoubet, B.; Sraer, J.-D.; Friedlander, G. 3-Hydroxy-3-methylglutarylCoenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ. Res. 1998, 83, 683-690.
41. Bourcier, T.; Libby, P. HMG CoA reductase inhibitors reduce plasminogen activator-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 556-562.
42. Undas, A.; Brummel, K.E.; Musial, J.; Mann, K.G.; Szczeklik, A. Simvastatin depresses blood clotting by inhibiting activation of prothrombin factor V, and factor XIII and by enhancing factor Va inactivation. Circulation 2001, 103, 2248-2253.
43. Nordoy, A.; Svensson, B.; Hansen, J.B. Atorvastatin and omega-3 fatty acids prtect against activation of the coagulation system in patients with combined hyperlipemia. J. Thromb. Haemost. 2003, 1, 690-697.
44. Morikawa, S.; Takabe, W.; Mataki, C.; Kanke, T.; Itoh, T.; Wada, Y.; Izumi, A.; Saito, Y.; Hamakubo, T.; Kodama, T. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in human umbilical vein endothelial cells. J. Atheroscler. Thromb. 2002, 9, 178-183.
45. Hajjar, I.; Schumpert, J.; Hirth, V.; Wieland, D.; Eleazer, G.P. The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J. Gerontol. A. Biol. Sci. Med. Sci. 2002, 57, M414-M418.
46. Jick, H.; Zornberg, G.L.; Jick, S.S.; Seshadri, S.; Drachman, D.A. Statins and the risk of dementia. Lancet 2000, 356, 1627-1631.
47. Rejnmark, L.; Buus, N.H.; Vestergaard, P.; Andreasen, F.; Larsen, M.L.; Mosekilde, L. Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur. J. Clin. Invest. 2002, 32, 581-589.
48. Leung, B.P.; Sattar, N.; Crilly, A.; Prach, M.; McCarey, D.W.; Payne, H.; Madhok, R.; Campbell, C.; Gracie, J.A.; Liew, F.Y.; McInnes, I.B. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J. Immunol. 2003, 170, 1524-1530.
49. Liappis, A.P.; Kan, V.L.; Rochester, C.G.; Simon, G.L. The effect of statins on mortality in patients with bacteremia. Clin. Infect. Dis. 2001, 33, 1352-1357.
50. Seeger, H.; Wallwiener, D.; Mueck, A.O. Statins can inhibit proliferation of human breast cancer cells in vitro. Exp. Clin. Endocrinol. Diabetes 2003, 111, 47-48.
51. Kusama, T.; Mukai, M.; Iwasaki, T.; Tatsuta, M.; Matsumoto, Y.; Akedo, H.; Inoue, M.; Nakamura, H. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invastion and metastatis. Gastroenterology 2002, 122, 308-317.
52. Miller, T.L.; Wolin, M.J. Inhibition of growth of methane-producting bacteria of the ruminant forestomach by hydroxymethylglutaryl-S CoA reductase inhibitors. J. Dairy Sci. 2001, 884, 1445-1448.
53. Creager, M.A.; Lüscher, T.F.; Cosentino, F.; Beckman, J.A. Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003, 108, 1527-1532.
54. Even-Ram, S.; Uziely, B.; Cohen, P.; Grisaru-Granolvsky, S.; Maoz, M.; Ginzburg, Y.; Reich, R.; Vlodavsky, I.; Bar-Shavit, R. Thrombin receptor overexpression in malignant and physiological invasion processes. Nature Med. 1998, 4, 909-914.
55. Y, Y.-J.; Salah, Z.; Gresaru-Granovsky, S.; Cohen, I.; Even-Ram, S.; Maoz, M.; Uziely, B.; Peretz, T.; Bar-Shavit, R. Human protease-activated receptor 1 expression in malignant epithelia. A role in invasiveness. Arteriosceleros. Thrombos. Vas. Biol. 2003, 23, 940-944.
56. Lefer, D.J. Statins as potent antiinflammatory drugs. Circulation 2002, 106, 2041-2042.
57. Burke, A.P.; Tracy, R.P.; Kolodgie, F.; Malcom, G.T.; Zieske, A.; Kutys, R.; Pestaner, J.; Smialek, J.; Virmani, R. Elevated C-reactive protein values and atherosclerosis in sudden coronary death. Association with different pathologies. Circulation 2002, 105, 2019-2023.
58. Plenge, J.K.; Hernandez, T.L.; Weil, K.M.B.; Poirier, P.; Grunwald, G.K.; Marcovina, S.M.; Eckel, R.H. Simvastatin lowers C-reactive protein within 14 days. An effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002, 106, 1447-1452.